Overview

Safety of Testosterone Undecanoate i.m. in Hypogonadal Men

Status:
Completed
Trial end date:
2007-01-01
Target enrollment:
Participant gender:
Summary
Treatment of male hypogonadism by testosterone substitution has be monitored in terms of safety. This study relates to safety of a new long-acting preparation.
Phase:
Phase 2
Details
Lead Sponsor:
University Hospital Muenster
Treatments:
Methyltestosterone
Testosterone
Testosterone 17 beta-cypionate
Testosterone enanthate
Testosterone undecanoate